A Real Shot in the Arm: The UK and US Forge a Groundbreaking Zero-Tariff Deal on Pharmaceuticals

Unpacking the Trump Administration's Bold Move to Cut Drug Costs

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

Eli Lilly Slashes Zepbound Prices Amid Political Pressure and Trump's Claims

India's Pharma Vision: Charting a Course for Global Leadership

The Market's Daily Pulse: What's Driving These Top Stocks into the Headlines?

Natco Pharma's Latest Earnings: A Closer Look at Resilience Amidst Market Shifts

A Game-Changer? Trump Set to Unveil Sweeping Healthcare Cost Framework

A Call to Conscience: Karnataka Minister's Stern Warning to Pharma Industry

From Humble Beginnings to Mar-a-Lago Splendor: The Billionaire Pharma Titan's Lavish Celebration

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Great Healthcare Tug-of-War: When Cutting Costs Clashes with the Promise of Cures

The Unfinished Reckoning: A Shadow Lingers Over the Sackler Settlement

The Reckoning Continues: Unpacking the Endless Aftermath of the Opioid Crisis

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

The Heartbeat of Pharma: Why Andhra's Small Businesses Are Vying for Space in Kanigiri

The Prescription Battle: Unpacking the Mail-Order Medication Showdown

The High Stakes Game: Dissecting Phathom Pharmaceuticals and Aravive's Biotech Fortunes

The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

AstraZeneca's Quiet Triumph: A Deeper Dive into Q3's Surprising Win

The Great Pharmaceutical Scramble: Pfizer Bags Metsea in High-Stakes Obesity Drug Duel

The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race

The High-Stakes Game of Weight Loss: Pfizer's Gambit in the GLP-1 Gold Rush

When Giants Shift: Mitsubishi UFJ's Calculated Bet on Biotech's Next Horizon

The Price of Progress? Unpacking the Billion-Dollar Buzz Around America's New Weight-Loss Fixes

The Shifting Sands of Capital: A Big Player Trims Its Biotech Bet

The GLP-1 Gambit: Pharma Giants, Trump, and the High Stakes of Drug Prices

The Great Drug Price Tug-of-War: Democrats Target a Rare Loophole

The Great GLP-1 Gambit: Navigating Novo Nordisk's Wild Ride

Alembic Pharma's Q2 Triumph: A Story of Strategic Growth and Solid Returns

Project Optimus: A Risky Gamble? Unpacking the FDA's New Approach to Cancer Drug Approval

The Pharma Giant's Pivot: Navigating Post-Pandemic Waters and the Oncology Horizon

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

Miracles & Mountains: Navigating the Brave New World of Biotech Medicines

A Brave New World of Medicine: Unpacking the Promise and Peril of Biotech Drugs

Beneath the Surface: Unpacking the Billions Driving Tomorrow's Cures Through Clinical Trial Networks

The Shifting Sands of Pharma: Why India's CDMOs Face a Defining Moment of Specialization

The Pharmaceutical Whirlwind: From Weight Loss Wonders to Mind-Altering Medicines, A New Era Unfolds